Immunoregulatory effects of adenosine 5′‐triphosphate on cytokine release from stimulated whole blood
- 22 February 2005
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 35 (3) , 852-858
- https://doi.org/10.1002/eji.200425423
Abstract
In vitro studies suggest that extracellular nucleotides and nucleosides may be important regulators of inflammatory and immune responses. Most studies with adenosine 5′-triphosphate (ATP) have been performed in cell lines, which are remote from the human situation. The purpose of the present study was to determine the effects of ATP on TNF-α, IL-6 and IL-10 release in stimulated whole blood. Blood samples were drawn from healthy volunteers and incubated with ATP and lipopolysaccharide (LPS) + phytohemagglutinin (PHA) for 24 h. Contrary to expectations, ATP at 100 μM and 300 μM induced a reduction in TNF-α secretion by 32±8% (mean ± SEM) and 65±4%, respectively. Furthermore, these ATP concentrations induced an increase in IL-10 secretion by 48±5% and 62±7% in whole blood. The ATP analogue adenosine 5′-O-(3-thiotriphosphate) (ATP-γ-S) and adenosine 5′-diphosphate (ADP) also inhibited TNF-α release, but only ADP showed a stimulatory effect on IL-10. Co-treatment with adenosine deaminase did not reverse the ATP effect on TNF-α and IL-10. These results show, for the first time, that ATP inhibits the inflammatory response in stimulated whole blood as indicated by inhibition of TNF-α and stimulation of IL-10 release and that this effect is predominantly mediated by ATP and not by adenosine.Keywords
This publication has 28 references indexed in Scilit:
- Revival of the regulatory Tcell: new targets for drug developmentDrug Discovery Today, 2004
- Randomized clinical trial of adenosine 5′-triphosphate on tumor growth and survival in advanced lung cancer patientsAnti-Cancer Drugs, 2003
- Immune responses in cancerPharmacology & Therapeutics, 2003
- Adenosine triphosphate infusion increases liver energy status in advanced lung cancer patients: An in vivo 31P magnetic resonance spectroscopy studyHepatology, 2002
- Type 1 T regulatory cellsImmunological Reviews, 2001
- The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine releaseThe FASEB Journal, 2000
- Pharmacological characterization of ATP‐ and LPS‐induced IL‐1β release in human monocytesBritish Journal of Pharmacology, 1999
- Extracellular ATP Activates Transcription Factor NF-κB through the P2Z Purinoreceptor by Selectively Targeting NF-κB p65 (RelA)The Journal of cell biology, 1997
- Purinergic Modulation of Interleukin-1β Release from Microglial Cells Stimulated with Bacterial EndotoxinThe Journal of Experimental Medicine, 1997
- The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell deathImmunology Today, 1995